Mikael was President and Head of R&D at Wyeth Pharmaceuticals, and Private Equity Partner at OrbiMed Advisors. Mikael Dolsten joined Agilent Technologies in 2026.
Mikael Dolsten is currently
Create your alert
to follow the career of Mikael Dolsten.
Mikael Dolsten has a Doctor of Medicine from Lund University.
They have also studied at Lund University :
Find more alumni from Lund University
Do you need to know more about Mikael Dolsten? More results.
Report an error
Update the org chart details of Mikael Dolsten.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.